| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP002922 |
|
50-63-5 |
Chloroquine Phosphate - 99% |
0 | C18H32ClN3O8P2 | |
| CP000459 |
|
68786-66-3 |
Triclabendazole - 99% |
0 | C14H9Cl3N2OS | |
| CP006049 |
|
124605-42-1 |
Methyl (2R,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-3-phenylpropionate - 98.0% |
0 | C15H21NO5 | |
| CP003306 |
![(1R,2S,4R)-rel-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol](/image/1705)
|
507-70-0 |
(1R,2S,4R)-rel-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol - |
0 | C10H18O | |
| CP007506 |
|
198637-52-4 |
Gadobutrol Monohydrate - 99% |
0 | C18H32GdN4O10 | |
| CP005719 |
|
7681-82-5 |
Sodium iodide - 99% |
0 | NAI | |
| CP003635 |
|
16909-11-8 |
3-(3,5-Dimethoxyphenyl)acrylic acid - 98% |
0 | C11H12O4 | |
| CP006568 |
|
19767-45-4 |
sodium 2-mercaptoethanesulfonate - |
0 | C2H5NAO3S2 | |
| CP007330 |
|
8068-28-8 |
Colistimethate sodium - 390μg/mg |
0 | C58H105N16Na5O28S5 | |
| CP002302 |
|
85409-38-7 |
(dicyclopropylmethyl)(4,5-dihydro-2-oxazolyl)ammonium dihydrogen phosphate - |
0 | C10H16N2O.H3O4P | |
| CP007049 |
|
630-56-8 |
17A-hydroxyprogesterone hexanoate - 97% |
0 | C27H40O4 | |
| CP005504 |
|
873857-62-6 |
FidaxoMicin - 98.7% |
0 | C52H74Cl2O18 | |
| CP004270 |
|
630420-16-5 |
BMS-650032 - |
0 | C35H46N5O9SCL | |
| CP004273 |
|
15307-79-6 |
Diclofenac sodium - 99% |
0 | C14H10Cl2NNaO2 | |
| CP008238 |
|
72830-09-2 |
2-(Chloromethyl)-3,4-dimethoxypyridine hydrochloride - 99% |
0 | C8H10NO2CL.HCL | |
| CP000025 |
|
53164-05-9 |
Acemetacin - 99.0%~101.0% |
0 | C21H18ClNO6 | |
| CP006365 |
|
528560-93-2 |
Telmisartan methyl ester - 98% |
0 | C34H32N4O2 | |
| CP005499 |
|
49761-82-2 |
tert-Butyl 1H-imidazole-1-carboxylate - |
0 | C8H12N2O2 | |
| CP006952 |
|
864821-90-9 |
Eluxadoline - |
0 | C32H35N5O5 | |
| CP003129 |
|
97468-37-6 |
Cephapirin benzathine - 97% |
0 | 2[C17H17N3O6S2].C16H20N2 | |
